IL15 and pancreatic adenocarcinoma: We have previously shown that NKT cell immunotherapy combined with VSV-GFP enhanced survival in an ID8 ovarian cancer model [13], and VSV expressing the cytokine IL-15 could combine with NKT cell immunotherapy to reduce growth of Panc02 pancreatic adenocarcinoma tumors [29].